FAK was reported to regulate TNFα and IL1β signaling-induced vascular endothelial adhesion molecule expression and has been demonstrated to be a therapeutic potential in the treatment of vascular inflammatory diseases and atherosclerosis (21). This evidence concerns the gene PTK2 and atherosclerosis.